Argentina
Colombia
Malaysia
Mexico
Other LatAm Countries
English
-
-
Dengue in the Midst of COVID-19 Pandemic
ADVA14 minutes -
The Shifting Epidemiology of Dengue: From Climate Change to Urbanization
Medscape5 minutes -
Dengue disease awareness
ISID39 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Controlling Dengue: Immunization Is a Pillar of Prevention
Medscape33 minutes -
Emerging Issues in Dengue Control
Takeda -
Dengue Prevention: Vaccination as Part of A Comprehensive Strategy for Disease Control
Takeda -
Dengue Vaccines
Takeda -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Surveillance and Reporting
Takeda5 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Antibody Levels over Time
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Differential diagnosis
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Clinical diagnosis and management of dengue
PAHO -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Dengue Clinical Case Management
CDC -
The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019
Takeda2 minutes -
Emerging Issues in Pediatric Dengue
WSPID50 minutes -
Antibody-dependent enhancement of severe dengue disease in humans
Takeda2 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Dengue fever and insecticide resistance in Aedes mosquitoes in Southeast Asia: a review
Takeda2 minutes -
Causes of fever in returning travelers: A European multicenter prospective cohort study
Takeda2 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Professor Adi Utarini – Eliminating Dengue
35 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
Dengue vector control: what works best
WSPID20 minutes -
Mosquito Longevity
ADVA22 minutes -
Dengue Prevention: Translating Knowledge into Action
Takeda -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023